In the room
An in-person visit
How the conversation works
You sit with the doctor and talk through your goal. Ask how an exam or a test would fit into the visit.
A question that opens the visit
Which health problem would this treatment address?
A guide to care choices
Explore the evidenceDiscuss your longevity goal before choosing a medicine
Begin with what you hope to change. Then compare how a doctor would assess that goal, explain the medicine, and follow up.

Peptides are small strings of the parts that build proteins.
Insulin is a familiar example.
The September 26, 2026 check of U.S. rules showed that “peptide therapy” did not identify a treatment as safe or allowed.
Ask for the medicine’s name. Then ask whether it is approved, made to order under pharmacy rules, or sold only for research.
In the room
You sit with the doctor and talk through your goal. Ask how an exam or a test would fit into the visit.
Which health problem would this treatment address?
From home
With telehealth, you receive care by video, by telephone, or by exchanging messages online.
Ask how the doctor will come back to you if an answer needs more detail.
Which tests or examinations would require me to attend in person?
Ask whether the proposed medicine is a ready-made approved product, a medicine made to order, or a research chemical.
With compounding, medicine is made or mixed to serve a patient rather than provided as a drug company’s finished product.
Medicine reviews are part of the work of the U.S. Food and Drug Administration, or FDA.
No FDA approval applied to compounded medicines at the September 26, 2026 check.
Before sale, FDA had not evaluated how well these medicines worked, their safety, or their quality.
Ozempic and Wegovy are brand names for the medicine semaglutide.
The September 26, 2026 FDA-approved uses included weight loss with Wegovy and, for adults managing type 2 diabetes, control of blood sugar with Ozempic.
These examples concern diabetes and weight. Ask what evidence supports the result you want from treatment for “longevity,” meaning a longer life.
Epitalon and MOTS-c are names of two peptides sold online.
FDA records checked September 26, 2026 showed no approved U.S. medicine containing either peptide.
A missing approval record does not, by itself, tell you whether pharmacy rules allow an ingredient to be made into medicine.
For pharmacies making medicine for individual patients, records checked September 26, 2026 showed that neither peptide met the required ingredient tests.
Neither was in an approved drug, had a recognized drug-ingredient standard, or was on the allowed-ingredient list.
Ask which condition the proposed peptide would treat, then ask to see human studies supporting that purpose. Ask the pharmacy which ingredient rule allows it to make your medicine.
Read what FDA approval meansA prescriber writes the prescription: the order for your medicine.
FDA’s explanation checked September 26, 2026 described compounding as an option for a patient whose medical needs could not be met by an approved drug.
Under rules checked September 26, 2026, pharmacies could not regularly make copies of ready-made medicines already available from drug companies.
A changed medicine is allowed when the prescription writer judges that the change makes a significant difference to that individual patient.
FDA’s examples include removing a dye because a patient is allergic to it, or changing the medicine’s form for someone who has trouble swallowing tablets.
Ask the prescription writer to describe the medicine’s planned changes and explain their importance for your own health.
Paying less, by itself, does not meet this test of a significant difference.
Read the FDA explanation of compounding